Development of oxidative stress in chronic kidney insufficiency following the progression of disease. 1997

P Bochev, and N Tzvetkov, and M Alexandrova, and M Magrisso, and B Bechev, and O Monovich, and V Markova

UI MeSH Term Description Entries
D007676 Kidney Failure, Chronic The end-stage of CHRONIC RENAL INSUFFICIENCY. It is characterized by the severe irreversible kidney damage (as measured by the level of PROTEINURIA) and the reduction in GLOMERULAR FILTRATION RATE to less than 15 ml per min (Kidney Foundation: Kidney Disease Outcome Quality Initiative, 2002). These patients generally require HEMODIALYSIS or KIDNEY TRANSPLANTATION. ESRD,End-Stage Renal Disease,Renal Disease, End-Stage,Renal Failure, Chronic,Renal Failure, End-Stage,Chronic Kidney Failure,End-Stage Kidney Disease,Chronic Renal Failure,Disease, End-Stage Kidney,Disease, End-Stage Renal,End Stage Kidney Disease,End Stage Renal Disease,End-Stage Renal Failure,Kidney Disease, End-Stage,Renal Disease, End Stage,Renal Failure, End Stage
D007677 Kidney Function Tests Laboratory tests used to evaluate how well the kidneys are working through examination of blood and urine. Function Test, Kidney,Function Tests, Kidney,Kidney Function Test,Test, Kidney Function,Tests, Kidney Function
D008054 Lipid Peroxides Peroxides produced in the presence of a free radical by the oxidation of unsaturated fatty acids in the cell in the presence of molecular oxygen. The formation of lipid peroxides results in the destruction of the original lipid leading to the loss of integrity of the membranes. They therefore cause a variety of toxic effects in vivo and their formation is considered a pathological process in biological systems. Their formation can be inhibited by antioxidants, such as vitamin E, structural separation or low oxygen tension. Fatty Acid Hydroperoxide,Lipid Peroxide,Lipoperoxide,Fatty Acid Hydroperoxides,Lipid Hydroperoxide,Lipoperoxides,Acid Hydroperoxide, Fatty,Acid Hydroperoxides, Fatty,Hydroperoxide, Fatty Acid,Hydroperoxide, Lipid,Hydroperoxides, Fatty Acid,Peroxide, Lipid,Peroxides, Lipid
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D018384 Oxidative Stress A disturbance in the prooxidant-antioxidant balance in favor of the former, leading to potential damage. Indicators of oxidative stress include damaged DNA bases, protein oxidation products, and lipid peroxidation products (Sies, Oxidative Stress, 1991, pxv-xvi). Anti-oxidative Stress,Antioxidative Stress,DNA Oxidative Damage,Nitro-Oxidative Stress,Oxidative Cleavage,Oxidative DNA Damage,Oxidative Damage,Oxidative Injury,Oxidative Nitrative Stress,Oxidative Stress Injury,Oxidative and Nitrosative Stress,Stress, Oxidative,Anti oxidative Stress,Anti-oxidative Stresses,Antioxidative Stresses,Cleavage, Oxidative,DNA Damage, Oxidative,DNA Oxidative Damages,Damage, DNA Oxidative,Damage, Oxidative,Damage, Oxidative DNA,Injury, Oxidative,Injury, Oxidative Stress,Nitrative Stress, Oxidative,Nitro Oxidative Stress,Nitro-Oxidative Stresses,Oxidative Cleavages,Oxidative DNA Damages,Oxidative Damage, DNA,Oxidative Damages,Oxidative Injuries,Oxidative Nitrative Stresses,Oxidative Stress Injuries,Oxidative Stresses,Stress Injury, Oxidative,Stress, Anti-oxidative,Stress, Antioxidative,Stress, Nitro-Oxidative,Stress, Oxidative Nitrative,Stresses, Nitro-Oxidative
D018450 Disease Progression The worsening and general progression of a disease over time. This concept is most often used for chronic and incurable diseases where the stage of the disease is an important determinant of therapy and prognosis. Clinical Course,Clinical Progression,Disease Exacerbation,Exacerbation, Disease,Progression, Clinical,Progression, Disease

Related Publications

P Bochev, and N Tzvetkov, and M Alexandrova, and M Magrisso, and B Bechev, and O Monovich, and V Markova
July 2014, Acta medica Indonesiana,
P Bochev, and N Tzvetkov, and M Alexandrova, and M Magrisso, and B Bechev, and O Monovich, and V Markova
July 2022, Antioxidants (Basel, Switzerland),
P Bochev, and N Tzvetkov, and M Alexandrova, and M Magrisso, and B Bechev, and O Monovich, and V Markova
May 2015, Iranian journal of kidney diseases,
P Bochev, and N Tzvetkov, and M Alexandrova, and M Magrisso, and B Bechev, and O Monovich, and V Markova
January 2016, Oxidative medicine and cellular longevity,
P Bochev, and N Tzvetkov, and M Alexandrova, and M Magrisso, and B Bechev, and O Monovich, and V Markova
January 2005, Nephrology nursing journal : journal of the American Nephrology Nurses' Association,
P Bochev, and N Tzvetkov, and M Alexandrova, and M Magrisso, and B Bechev, and O Monovich, and V Markova
June 2019, Pediatric nephrology (Berlin, Germany),
P Bochev, and N Tzvetkov, and M Alexandrova, and M Magrisso, and B Bechev, and O Monovich, and V Markova
April 1976, Nederlands tijdschrift voor geneeskunde,
P Bochev, and N Tzvetkov, and M Alexandrova, and M Magrisso, and B Bechev, and O Monovich, and V Markova
January 2008, The Veterinary clinics of North America. Small animal practice,
P Bochev, and N Tzvetkov, and M Alexandrova, and M Magrisso, and B Bechev, and O Monovich, and V Markova
April 2011, Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy,
P Bochev, and N Tzvetkov, and M Alexandrova, and M Magrisso, and B Bechev, and O Monovich, and V Markova
January 2009, Seminars in dialysis,
Copied contents to your clipboard!